Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6240)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2013 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World J Gastroenterol 2013; 19(21): 3207-3216 [PMID: 23745022 DOI: 10.3748/wjg.v19.i21.3207] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i21/3207.htm |
| Number | Citing Articles |
| 1 |
Xiaobin Feng, Yongjie Su, Shuguo Zheng, Feng Xia, Kuansheng Ma, Jun Yan, Xiaowu Li, Wei Tang, Shuguang Wang, Ping Bie, Jiahong Dong. A double blinded prospective randomized trial comparing the effect of anatomic versus non-anatomic resection on hepatocellular carcinoma recurrence. HPB 2017; 19(8): 667 doi: 10.1016/j.hpb.2017.04.010
|
| 2 |
Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells. Clinical and Molecular Hepatology 2015; 21(1): 49 doi: 10.3350/cmh.2015.21.1.49
|
| 3 |
Changqing Zhao, Feng Xing, Yee Hui Yeo, Michelle Jin, Richard Le, Michael Le, Mingjuan Jin, Linda Henry, Ramsey Cheung, Mindie H. Nguyen. Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2020; 32(3): 406 doi: 10.1097/MEG.0000000000001523
|
| 4 |
Won Sohn, Yong-Han Paik, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim, Ju Yeon Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation. Scandinavian Journal of Gastroenterology 2014; 49(3): 373 doi: 10.3109/00365521.2013.871745
|
| 5 |
Matea Majerović, Mislav Jelaković, Marina Premužić, Ivana Knežević Štromar, Davor Radić, Marko Mance, Stjepko Pleština, Rajko Ostojić, Nadan Rustemović, Zeljko Krznarić. Hepatocellular Carcinoma Surveillance—Experience from Croatian Referral Centre for Chronic Liver Diseases. Journal of Gastrointestinal Cancer 2019; 50(1): 48 doi: 10.1007/s12029-017-0011-1
|
| 6 |
Christian Bracco, Marta Gallarate, Marco Badinella Martini, Corrado Magnino, Salvatore D'Agnano, Roberta Canta, Giulia Racca, Remo Melchio, Cristina Serraino, Valentina Polla Mattiot, Giovanni Gollè, Luigi Fenoglio. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World Journal of Gastrointestinal Oncology 2024; 16(3): 761-772 doi: 10.4251/wjgo.v16.i3.761
Abstract(70) |
Core Tip(75) |
Full Article(HTML)(762)
|
Full Article with Cover (PDF)-1711K(13)
|
Full Article (Word)-368K(0)
|
Audio-787K(2)
|
Peer-Review Report-172K(6)
|
Answering Reviewers-132K(7)
|
Full Article (PDF)-1443K(24)
|
Full Article (XML)-131K(7)
|
Times Cited (0)
|
Total Visits (1276)
|
Open
|
| 7 |
Erin Wolf, Nicole E. Rich, Jorge A. Marrero, Neehar D. Parikh, Amit G. Singal. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis. Hepatology 2021; 73(2): 713 doi: 10.1002/hep.31309
|
| 8 |
Ahmed M Badheeb, Mohammed K Al Sedran, Faisal Ahmed, Ibrahim K Al Sidran, Mohammed H Al Qurayshah, Abdullah Abu Bakar, Hamoud Y Obied, Islam A Seada, Abdelaziz Aman, Mohamed Badheeb. Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia. Cureus 2024; doi: 10.7759/cureus.52608
|
| 9 |
Deniz Şumnulu. Contrary to known silibinin is not an anticancer agent and liver protective supplement. Genetika 2023; 55(2): 553 doi: 10.2298/GENSR2302553S
|
| 10 |
Abdulrahman A. Aljumah, Hadi Kuriry, Mohammed AlZunaitan, Mohammed Al Ghobain, Mohamed Al Muaikeel, Ashwaq Al Olayan, Fahad Azzumeea, Bader Almutairi, Abduljaleel AlAlwan, Hamdan AlGhamdi. Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1989045
|
| 11 |
Wenqian Qi, Qian Zhang, Yan Xu, Xu Wang, Fan Yu, Yonggui Zhang, Ping Zhao, Honghua Guo, Changyu Zhou, Zhe Wang, Yu Sun, Lin Liu, Wei Xuan, Jiangbin Wang. Peg‐interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti‐HBV efficacy and long‐term survival among HBV DNA‐positive hepatocellular carcinoma patients after hepatectomy/ablation. Journal of Viral Hepatitis 2020; 27(4): 387 doi: 10.1111/jvh.13236
|
| 12 |
Linda L. Wong, Makoto Ogihara, Junfang Ji, Naoky Tsai. The changing characteristics of hepatocellular cancer in Hawaii over time. The American Journal of Surgery 2015; 210(1): 146 doi: 10.1016/j.amjsurg.2014.06.036
|